Hydroxy Cyclophosphamide Semicarbazone-d4 (CAS 53948-46-2 (unlabeled))

Hydroxy Cyclophosphamide Semicarbazone-d4 is a chemically labeled derivative of Hydroxy Cyclophosphamide Semicarbazone. It has been studied for its potential applications in scientific research, particularly in the field of chemotherapy. Hydroxy Cyclophosphamide Semicarbazone-d4 is a modified form of Hydroxy Cyclophosphamide Semicarbazone that incorporates deuterium atoms (heavy hydrogen) into its chemical structure. One significant scientific application of Hydroxy Cyclophosphamide Semicarbazone-d4 is its use as a tracer in pharmacokinetic and pharmacological studies. By utilizing the labeled compound, researchers can monitor the distribution, metabolism, and elimination of Hydroxy Cyclophosphamide Semicarbazone in the body. This information is for understanding the pharmacokinetics and optimizing the dosing regimens of drugs in chemotherapy. The mechanism of action of Hydroxy Cyclophosphamide Semicarbazone-d4 is similar to that of Hydroxy Cyclophosphamide Semicarbazone itself. Hydroxy Cyclophosphamide Semicarbazone is an active metabolite of the anticancer drug cyclophosphamide. It exerts its effects by undergoing metabolic activation in the liver, leading to the formation of alkylating metabolites. These metabolites interact with DNA, causing cross-linking and damage to the DNA strands. As a result, the replication and division of cancer cells are impaired, leading to cell death.